Wegovy Lowered Users’ Heart Risks in New Trial
TUESDAY, Aug. 8, 2023 (HealthDay News) — A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect.Taking the medication cut the risk of serious heart problems by 20%, drug maker No…
Learn MoreUna demanda contra los fabricantes de Ozempic y Mounjaro sostiene que provocaron una ‘parálisis estomacal’
JUEVES, 3 de agosto de 2023 (HealthDay News) — Una mujer de Luisiana está demandando a los fabricantes de dos medicamentos para la diabetes tipo 2 que se usan fuera de etiqueta para la obesidad, y afirma que no advirtieron de forma adecuada sobre el …
Learn MoreLawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach problems.The lawsuit seeks “very signific…
Learn MoreLawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.The lawsuit seeks “very significa…
Learn MoreTime-Restricted Eating May Aid Weight Loss With Type 2 Diabetes
THURSDAY, July 27, 2023 (HealthDay News) — Time-restricted eating (TRE) may help people with type 2 diabetes lose weight, according to a study presented during NUTRITION 2023, the annual meeting of the American Society for Nutrition, held from July 2…
Learn MoreEl ayuno de agua: ¿Es seguro? ¿Es para usted?
MIÉRCOLES, 12 de julio de 2023 (HealthDay News) — El ayuno de agua se ha convertido en una de las nuevas sensaciones para perder peso más de moda, y tanto exdeportistas como gurús del bienestar lo alaban. Pero puede recuperar con rapidez cualquier pe…
Learn MoreReguladores europeos investigan el riesgo de ideación suicida con unos populares fármacos para perder peso
MARTES, 11 de julio de 2023 (HealthDay News) — La Agencia Europea de Medicamentos (European Medicines Agency, EMA) está investigando preocupaciones de que Ozempic y Saxenda, unos populares medicamentos para perder preso, pudieran estar vinculados con…
Learn MoreWater Fasting: Is It Safe? Is It for You?
WEDNESDAY, July 12, 2023 (HealthDay News) — Water fasting has become one of the trendiest new weight-loss sensations, touted by former athletes and wellness gurus.But whatever weight is lost during a water fast can come back quickly, while other heal…
Learn MoreEuropean Regulators Investigating Risk for Suicidal Thoughts With Popular Weight-Loss Drugs
TUESDAY, July 11, 2023 (HealthDay News) — The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm.Three case reports from Iceland spu…
Learn MoreRisk of Suicidal Thoughts With Popular Weight-Loss Drugs Being Investigated by European Regulators
TUESDAY, July 11, 2023 (HealthDay News) — The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm.Three case reports from Iceland spu…
Learn More